To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
Public ClinicalTrials.gov record NCT00430716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A MULTINATIONAL, MULTICENTRE, RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF 1MG, 5MG AND 20 MG TID OF ORAL SILDENAFIL IN THE TREATMENT OF SUBJECTS AGED 18 YEARS AND OVER WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To demonstrate a dose response for 1 mg, 5 mg and 20 mg TID oral sildenafil for the treatment of subjects with PAH.
Study identification
- NCT ID
- NCT00430716
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 8, 2008 (Actual)
- Primary completion
- May 25, 2010 (Actual)
- Completion
- May 25, 2010 (Actual)
- Last update posted
- Dec 22, 2020
2008 – 2010
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Pulmonary Specialists, LTD | Phoenix | Arizona | 85013 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| Atlanta Institute for Medical Research, Inc. | Decatur | Georgia | 30030 | — |
| Chicago Heart Institute | Elk Grove Village | Illinois | 60007 | — |
| The Care Group, LLC | Indianapolis | Indiana | 46260 | — |
| The University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Mid Carolina Cardiology | Charlotte | North Carolina | 28204 | — |
| Presbyterian Hospital | Charlotte | North Carolina | 28204 | — |
| Baylor College of Medicine Pulmonary Section | Houston | Texas | 77030 | — |
| St. Luke's Episcopal Hospital | Houston | Texas | 77030 | — |
| University of Utah Sciences Center | Salt Lake City | Utah | 84132 | — |
| CJW Chippenham Medical Center | Richmond | Virginia | 23225 | — |
| Pulmonary Associates of Richmond, Inc. | Richmond | Virginia | 23225 | — |
| Virginia Cardiovascular Specialists | Richmond | Virginia | 23225 | — |
| Cardiovascular Associates of Virginia | Richmond | Virginia | 23230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00430716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00430716 live on ClinicalTrials.gov.